Abstract
Background and objective
Advanced age, co-morbid diseases, functional dependence and frailty are associated with polypharmacy and overall high health expenditures. Polypharmacy is commonly defined as the concomitant ingestion of four or more medications, particularly in community-dwelling patients, but the number of drugs being taken by institutionalised and hospitalised patients may be as high as ten. The aim of this study was to compare drug use in newly admitted patients (AP) to a geriatric medical centre for long-term care (LTC) with that of institutionalised patients (IP) at the centre.
Methods
A cross-sectional study was conducted, between January 2001 and December 2002, in 324 functionally dependent and cognitively impaired elderly patients (≥65 years of age), consisting of 167 IP (127 females, 40 males) staying at the centre for ≥3 months and 157 (117 females, 40 males) consecutive new admissions for LTC. All patients underwent a comprehensive geriatric assessment, which included a structured medical history, history of drug use, physical examination and functional and cognitive examinations. Overall drug use, drug categories and the basis of use (regular and/or as needed) were compared between the two groups of patients. The pattern of drug use was defined as use of drugs either on a ‘regular’ basis or on an ‘as needed’ basis at any time during the 3 weeks preceding the comprehensive geriatric assessment.
Results
IPs were younger, more dependent, more cognitively impaired, had more co-morbidity and had nonsignificantly higher overall drug use than APs. APs used drugs mainly on a ‘regular’ basis. All of the IPs and most (97%) of the APs were taking drugs according to regular regimens. However, advanced age in IPs was associated with lower overall drug use, predominantly of medications taken on a ‘regular’ basis, and higher use of drugs taken on an ‘as needed’ basis, whereas in APs, advanced age was associated with higher use of both types of medications.
Conclusion
IPs used more drugs on an ‘as needed’ basis, probably because of closer medical supervision of these patients than those in the community. Better knowledge of the patient’s medical condition and treatment, together with better monitoring in the community through patient caregiver instruction, on the one hand, and computerisation of medical data accessible to all healthcare providers, on the other hand, might reduce drug use on a regular basis and, consequently, the costly and adverse effects of polypharmacy.
Similar content being viewed by others
Notes
The use of trade names is for product identification purposes only and does not imply endorsement.
References
Fuchs Z, Novikov I, Blumstein T, et al. Patterns of drug use among the community-dwelling old-old population in Israel. Isr Med Assoc J 2003; 5: 346–51
United Nations. World population prospects: the 2000 revision and world urbanization prospects. New York: Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2002
Federal Interagency Forum on Aging-Related Statistics. Older Americans 2000: key indicators of well-being, population [online]. Available from URL: http://www.agingstats.gov/chartbook2000/default.htm [Accessed 2006 Jan 10]
The population in Israel, by religion, sex, age: end of year 2004 [online]. Available from URL: http://wwwl.cbs.gov.il/Society&Population/Population&Demography/popisrTable3PDF [Accessed 2006 Jan 10]
Central Bureau of Census. Projections of population in Israel for 2010–2025, by sex age and population group [online]. Available from URL: http://wwwl.cbs.gov.il/Society&Population/Population&Demography/popisr/Table5PDF [Accessed 2006 Jan 10]
Shmueli A. Levy Y. Utilization of health care services in Israel by age [in Hebrew]. Bitachon Sociali 1996; 49: 146–53
The 65+, numbers and facts [in Hebrew]. Jerusalem: Mashav, Eshel, Joint-Brookdale Institute for Gerontology and Development of Man and Society, 2002
Habot B, Tsin S. Geriatrics in the new millennium, Israel. Isr Med Assoc J 2003; 5: 319–21
Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol 1992; 42: M137–44
Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20: 817–32
Chutka DS, Takahashi PY, Hoel RW. Inappropriate medications for elderly patients. Mayo Clin Proc 2004; 79: 122–39
AARP administration on aging: a profile of older Americans, 1999. Washington, DC: AARP (American Association of Retired Persons), 1999
Kagansky N, Berner Y, Koren-Morag N, et al. Poor nutritional habits are predictors of poor outcome in very old hospitalized patients. Am J Clin Nutr 2005; 82: 784–91
Klang S. Drug prescription in Clalit Health Services: an unpublished presentation by the Head of Clinical Pharmacology Clalit Health Services in an internal conference of General and Geriatric Medicine at Meir Medical Center. Kfar Saba, Israel: Meir Medical Center, 2004 Nov 26 (Data on file)
Feldman J, Peleg L, Yaretzky A. Comprehensive geriatric assessment: its clinical, social and economic importance and prospects. Harefuah 1999; 136: 933–5
Ellis G, Langhorne P. Comprehensive geriatric assessment for older hospital patients. Brit Med Bull 2005; 71: 45–59
Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98
Katz S, Ford AB, Moskowitz RW. The index of ADL, a standardized measure of biological and psychological function. JAMA 1963; 185: 914–9
Bjerrum L, Søgaard J, Hallas J, et al. Polypharmacy: correlations with sex, age and drug regimen: a prescription database study. Eur J Clin Pharmacol 1998; 54: 197–202
Kroenke K. Polypharmacy: causes, consequences, and cure. Am J Med 1985; 79: 149–52
Giron MST, Wang H-X, Bernstein C, et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 2001; 49: 277–83
Giron MST, Claesson C, Thorslund M. Drug use patterns in a very elderly population: a seven-year review. Clin Drug Invest 1999; 17: 389–98
Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002; 55: 809–17
Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Int Med 1995; 123: 195–204
Fuchs Z, Blumstein T, Novikov I, et al. Morbidity, comorbidity and their association with disability among community dwelling oldest-old in Israel. J Gerontol Med Sci 1998; 53A: M447–55
Lassila HC, Stoehr GP, Ganguli M, et al. Use of prescription medications in an elderly rural population: the MoVIES Project. Ann Pharmacother 1996; 30: 589–95
Jylhä M. Ten-year change in the use of medical drugs among the elderly: a longitudinal study and cohort comparison. J Clin Epidemiol 1994; 47: 69–79
Helling DK, Lemke JH, Semla TP, et al. Medication use characteristics in the elderly: the Iowa 65+ Rural Health Study. J Am Geriatr Soc 1987; 35: 4–12
Barat I, Andreasen F, Damsgaard EMS. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000; 56: 501–9
Jorgensen T, Johansson S, Kennerfalk A, et al. Prescribing drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001; 35: 1004–9
Thomas HF, Sweetnam PM, Janchawee B, et al. Polypharmacy among older men in South Wales. Eur J Clin Pharmacol 1999; 55: 411–5
Rumble RH, Morgan K. Longitudinal trends in prescribing for elderly patients: two surveys four years apart. Br J Gen Pract 1994; 44: 571–5
Rovner BW, German PS, Broadhead J, et al. The prevalence and management of dementia and other psychiatric disorders in nursing homes. Int Psychogeriatr 1990; 2: 13–24
Beardsley RS, Larson DB, Burns BJ, et al. Prescribing of psychotropics in elderly nursing home patients. J Am Geriatr Soc 1989; 37: 327–30
Avorn J, Dreyer P, Connelly K, et al. Use of psychoactive medication and the quality of care in rest homes: findings and policy implications of statewide study. N Engl J Med 1989; 320: 227–32
Everitt DE, Fields DR, Soumerai SS, et al. Resident behavioral and staff distress in the nursing home. J Am Geriatr Soc 1991; 39: 792–8
Beers M, Avorn J, Soumerai SB, et al. Psychoactive medication use in intermediate-care facility residents. JAMA 1988; 260: 3016–20
van Dijk KH, de Vries CS, van den Berg PB, et al. Drug utilization in Dutch nursing homes. Eur J Clin Pharmacol 2000; 55: 765–71
Claesson CB. Drug use in Swedish nursing home. Clin Drug Invest 1998; 16: 441–52
Snowdon J, Vaughan R, Miller R, et al. Psychotropic drug use in Sydney nursing homes. Med J Aust 1995; 163: 70–2
Fahey T, Montgomery AA, Barnes J, et al. Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. BMJ 2003; 326: 580–5
Stoehr GP, Ganguli M, Seaberg EC, et al. Over-the-counter medication use in an older rural community: the MoVIES project. J Am Geriatr Soc 1997; 45: 158–65
Wasserfallen JB, Bourgeois R, Büla C, et al. Composition and cost of drugs stored at home by elderly patients. Ann Pharmacother 2003; 37: 731–7
Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure survey. J Am Geriatr Soc 2005; 53: 438–43
Acknowledgements
No sources of funding were used to assist in the preparation of this study. The authors have no conflicts of interest that are directly relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arinzon, Z., Peisakh, A., Zuta, A. et al. Drug Use in a Geriatric Long-Term Care Setting. Drugs Aging 23, 157–165 (2006). https://doi.org/10.2165/00002512-200623020-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200623020-00005